AQR Capital Management »

Tarsus Pharmaceuticals shares owned by AQR Capital Management

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $371k 10k 36.35

More positions owned by AQR Capital Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Cisco Systems (CSCO)
General Electric Com New (GE)
Broadcom (AVGO)
McKesson Corporation (MCK)
Adobe Systems Incorporated (ADBE)
Alphabet Cap Stk Cl C (GOOG)
Everest Re Group (EG)
Cardinal Health (CAH)
Johnson & Johnson (JNJ)

View all positions for AQR Capital Management

Top funds holding Tarsus Pharmaceuticals

Paradigm Biocapital Advisors
BlackRock
Morgan Stanley
Tang Capital Management
Cormorant Asset Management
Cowen And Company
Vanguard Group
Frazier Life Sciences Management
Jennison Associates
Perceptive Advisors
Ikarian Capital
Ensign Peak Advisors
Geode Capital Management
Artisan Partners Limited Partnership
Boone Capital Management

View all funds holding Tarsus Pharmaceuticals